Clinical trial
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic…
NCT00281892 · German CLL Study Group, Other · Completed
Key facts
| NCT number | NCT00281892 |
|---|---|
| Title | Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia |
| Official title | Darbepoetin Alfa in Patients With Chronic Lymphocytic Leukemia and Comorbidity |
| Lead sponsor | German CLL Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia, Anemia |
| Intervention type | Biological, Drug |
| Interventions | Fludarabine plus Darbopoetin, Fludarabine mono |
| Enrollment | 97 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | Oct 1, 2010 |
| First posted | Jan 25, 2006 |
| Last update posted | May 11, 2018 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: